- Home
- / GEN
GEN
Stock Price
₺82
2024-10-28
Market Capitalization
₺24.6 B
2024-10-28
Revenue
₺19.2 B
FY, 2025
GEN Summary
Company Summary
- Overview
- GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret is a company that develops and manufactures pharmaceutical products. It specializes in treatments for neurology, endocrinology, nephrology, oncology, hematology, and pediatrics.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Ankara, TR | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Ankara, Ankara HQ
Turkey
Mustafa Kemal Mahallesi 2119.Cad. No:3
GEN Financials
Summary Financials
- Revenue (Q1, 2026)
- ₺6.6B
- Gross profit (Q1, 2026)
- ₺2.1B
- Net income (Q1, 2026)
- ₺374.4M
- Cash (Q1, 2026)
- ₺275.4M
- EBIT (Q1, 2026)
- ₺1.1B
- Enterprise value
- $29.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026